高级检索
当前位置: 首页 > 详情页

Correlation of IL-27 genetic polymorphisms with the risk and survival of cervical cancer in a Chinese Han population

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Medical Oncology, Fourth Hospital of HebeiMedical University, Shijiazhuang 050011, Hebei, China [2]College of Science and Technology, Yichang 443002, Hubei, China [3]Department of Pathology, Bethune International Peace Hospital, Shijiazhuang 050000, Hebei, China [4]Xingtai National Hospital, Xingtai 054000, Hebei, China
出处:
ISSN:

关键词: IL-27 Cervical cancer Single nucleotide polymorphism Susceptibility

摘要:
Interleukin-27 (IL-27) has been recognized as a pleiotropic cytokine with both pro- and anti-inflammatory properties. However, there are no data about the role of IL-27 polymorphism in the development of cervical cancer. A hospital-based case control study was conducted in 380 patients with cervical cancer and 380 healthy controls to investigate the possible associations of IL-27 gene polymorphisms (-964A/G, 29051/G, and 47301/C), with susceptibility to cervical cancer and clinical outcome. Our results suggested that the IL-27 29051/G was significantly associated with a decreased risk of cervical cancer (TG vs. IT, odds ratio (OR)=0.77; 95 % confidence interval (CI)=0.60-0.86; GG vs. TT, OR=0.95; 95 0 CI=0.72-0.96; TG+GG vs. TT, OR=0.87; 95 % CI=0.65-0.94). However, the genotype and allele frequencies of IL-27 (-964A/G and 47301/C) polymorphisms in cervical cancer patients were not significantly different from controls. Further analysis showed IL-27 2905T/G genotypes were associated with advanced tumor stages of cervical cancer patients. More interestingly, the IL-27 2905T/G genotypes were statistically significantly associated with the survival in cervical cancer patients. Our results showed that the IL-27 29051/G genotypes were associated with decreased susceptibility and development of cervical cancer in Chinese Han population.

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2016]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
最新[2025]版:
JCR分区:
出版当年[2016]版:
Q2 ONCOLOGY
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版]

第一作者:
第一作者机构: [1]Department of Medical Oncology, Fourth Hospital of HebeiMedical University, Shijiazhuang 050011, Hebei, China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号